ANGLE
LIVE

Serial Number

79204258

Owner

ANGLE EUROPE LIMITED

Attorney

Christina M. Licursi

Filing Date

Dec 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ANGLE Trademark

Serial Number: 79204258 • Registration: 5505329

ANGLE is a trademark filed by ANGLE EUROPE LIMITED on December 21, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ANGLE EUROPE LIMITED (28 trademarks)

10 NUGENT ROAD
GUILDFORD GU2 7AF , GB

Entity Type: 03

Trademark Details

Filing Date

December 21, 2016

Registration Date

July 3, 2018

Published for Opposition

April 17, 2018

Goods & Services

Biological [ , scientific ] and medical research and consultation services related thereto; [ product research and development in the fields of biology and medical sciences; custom development of biochemical reagents; ] services of a chemical laboratory; medical research laboratory services, in particular in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders

[ Diagnostic reagents and assay components for clinical, medical and medical laboratory use; diagnostic kits comprised of diagnostic reagents and assay components for clinical, medical and medical laboratory use; not including any such goods that are prescription only pharmaceuticals, but including such non-pharmaceutical goods that are for companion diagnostics ]

Diagnostic preparations and reagents for scientific or research use; chemical reagents for non-medical purposes; reagents for in vitro use; chemical preparations in the nature of [ buffer solutions and ] reagents for scientific and research use for use with laboratory apparatus, namely, separation apparatus [ and analysis apparatus ] ; [ biomarkers, namely, molecular biomarkers for scientific or research use; ] chemical test kits and diagnostic kits comprised of diagnostic reagents and assay components for scientific, research, clinical and medical laboratory use

Apparatus, equipment and instruments for scientific, laboratory, diagnostic or general research use, namely, laboratory analyzers, pre-packed columns for use in separation and purification, glassware, tubes, namely, sample tubes, reagent tubes, [ phlebotomy tubes and plastic tubes ] ; apparatus, equipment and instruments, namely, cassettes for harvesting cancer cells, for cytology, histology and for use in detecting cancerous conditions for laboratory or research use; apparatus in the nature of cassettes for harvesting rare cells for use in laboratory, diagnostic or general research use; cell analyser providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor for harvesting rare cells; apparatus for use in testing and analysing blood and blood cells for laboratory or research use; [ diagnostic reagent kits for the analysis of data and test results, all for laboratory use, and none for medical use; biological analysis computer software; ] parts and fitting for the aforesaid goods, namely medical laboratory research instruments for use in the detection of cancer

Medical diagnostic apparatus, equipment and instruments for clinical diagnosis of cancer, namely, apparatus for medical diagnostic testing in the field of cancer; [ medical testing apparatus, equipment and instruments; ] medical testing kits consisting primarily of medical diagnostic apparatus for testing body fluids including blood and plasma, rare cells for use in detecting cancerous conditions; parts and fittings for the aforesaid goods, namely, diagnostic apparatus, equipment and instruments for cytology, histology and for use in detecting cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 28, 2025 NREP
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 14, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 14, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jan 14, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 13, 2025 APRE
TEAS SECTION 71 RECEIVED
Jul 2, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 3, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 26, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 5, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 5, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 3, 2018 R.PR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 15, 2018 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 17, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Apr 13, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 28, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 28, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 28, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 27, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 6, 2017 GNFN
FINAL REFUSAL E-MAILED
Nov 6, 2017 GNFR
FINAL REFUSAL WRITTEN
Nov 6, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2017 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 26, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 26, 2017 REAP
REFUSAL PROCESSED BY IB
Apr 29, 2017 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 7, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 7, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 7, 2017 RFCR
APPLICATION FILING RECEIPT MAILED
Apr 7, 2017 MAFR
NON-FINAL ACTION WRITTEN
Apr 6, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 3, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 3, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 30, 2017 REPR